Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H2HZ
|
|||
| Drug Name |
GSK2646264
|
|||
| Synonyms |
CQLSAYKHANAIMX-UHFFFAOYSA-N; GTPL10108; compound 44 [PMID: 30249354]; 7-{2-methoxy-6-[(4-methylpyridin-2-yl)methoxy]phenyl}-2,3,4,5,5a,9a-hexahydro-1H-3-benzazepine
Click to Show/Hide
|
|||
| Indication | Cutaneous lupus erythematosus [ICD-11: EB5Z; ICD-10: L80-L99, L93; ICD-9: 710] | Phase 1 | [1] | |
| Urticaria [ICD-11: EB00-EB05; ICD-10: L50] | Phase 1 | [1] | ||
| Company |
GlaxoSmithKline Research Triangle Park, NC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H26N2O2
|
|||
| Canonical SMILES |
CC1=CC(=NC=C1)COC2=CC=CC(=C2C3=CC4=C(CCNCC4)C=C3)OC
|
|||
| InChI |
1S/C24H26N2O2/c1-17-8-13-26-21(14-17)16-28-23-5-3-4-22(27-2)24(23)20-7-6-18-9-11-25-12-10-19(18)15-20/h3-8,13-15,25H,9-12,16H2,1-2H3
|
|||
| InChIKey |
KYANYGKXMNYFBX-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1398695-47-0
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.